The Bariatric Surgery Devices Market Size was valued at USD 2.2 billion in 2022 and is projected to grow from USD 2.33 Billion in 2023 to USD 3.5 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.1% during the forecast period (2023 - 2032). Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. These are just a few of the market drivers that are driving the market.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
In August 2022: Standard Bariatrics was announced as being purchased by Teleflex for $170 million in upfront cash and up to an additional $130 million if certain commercial milestones are met.
January 2022: The first Complete Robotic Bariatric surgery was conducted at Apollo Hospital Hyderabad on Sunday which was a first-of-its-kind operation in Telugu states. The surgery involved a 180 kg weighing Somali woman aged 40 years old called Hibibo Abdulle Mohamed, who had health challenges.
Standard Bariatrics, Inc. achieved an important milestone on this journey when their Titan SGS surgical stapler technology hit its one-thousandth successful clinical case in January 2022. As a result, there have been improved outcomes with respect to the customization of Titan SGS into bariatric operations, leading to reduced length of procedure and better results.
Additionally, it should be noted that Olympus introduced POWERSEAL advanced bipolar surgical energy devices in September 2021 to strengthen its surgical portfolio. It can be employed for various types of surgical interventions, including bariatric surgeries.
Similarly, Ethicon launched ENSEAL X1 Curved Jaw Tissue Sealer for colorectal, gynecological, bariatric surgery and thoracic procedures, among others, as part of Johnson & Johnson Medical Devices Companies’ portfolio in June 2021. These major players have also made new product launches using new closing devices, thereby increasing the growth rate within the studied market.
For example, Standard Bariatrics announced the introduction of Titan SGS stapling technology designed specifically for bariatric sleeve surgery in May 2021. Also, it has cleared FDA regulations. These major players have also made new product launches using new closing devices, thereby increasing the growth rate within the studied market.
The primary driver of the market is the rising prevalence of adult obesity and the increased operational effectiveness of cutting-edge robotic technologies. The (NICE) National Institute for Health and Care Excellence recommended that bariatric surgery be considered earlier for persons with diabetes mellitus than lifestyle changes and medication. In the upcoming years, these innovations are anticipated to accelerate market expansion. Additional projected market expansion drivers include expanding reimbursement coverage and sponsored bariatric procedures by regional governments of developed countries.
Intragastric balloons were added to the American Society for Metabolic and Bariatric Surgery's (ASMBS) list of suggested devices for use during bariatric surgeries in February 2018. Three of these devices were approved in Europe, and the FDA also approved these devices in the US in 2015–16. It is predicted that these endorsements and recommendations will significantly accelerate market expansion. Thus, this factor is driving the market CAGR.
An analysis of 2016 WHO data shows that 1.9 billion people are overweight, of which 650 million are obese. Around 13% of people over the age of 18 and 41 million children under the age of 5 are fat, according to statistics. The American Heart Association predicts that by 2030, the entire cost of medical care might increase to USD 957 billion from USD 861 billion. The government is acting to minimize the prevalence of obesity and its long-term chronic disorders because of the enormous healthcare spending. The District of Columbia and 50 states received funding from the Centers for Disease Control and Prevention (CDC) in 2017 to improve initiatives. Thus, it is anticipated that this aspect will accelerate Bariatric Surgery Devices market revenue globally.
The market segments of Bariatric Surgery Devices, based on type includes, minimally invasive surgical devices, non-invasive surgical devices. The minimally invasive surgical devices segment held the majority share in 2022 in the Bariatric Surgery Devices market data. The popularity of this minimally invasive procedure for this surgery has increased over the past ten years, along with the growing acceptability of laparoscopic surgery. With a smaller incision, laparoscopic surgery is more convenient for patients. Due to this procedure, the stomach is reduced to a tiny pouch, and little food may enter the small intestine. The small intestine is bypassed, which reduces nutrition and fat absorption and aids in weight loss.
The Bariatric Surgery Devices market segmentation, based on procedure includes sleeve gastrectomy, gastric bypass, revision surgery, adjustable gastric band. The sleeve gastrectomy segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2032. As sleeve gastrectomy was recently approved by the FDA and required no incisions, this market is anticipated to expand at the fastest rate throughout the projected period. In recent years, this process has undergone several changes. The majority (42.1%) of the 179,000 procedures conducted, according to the American Society for Metabolic and Bariatric Surgery (ASMBS), were sleeve gastrectomy, followed by gastric bypasses, hence contributing in the market growth of the Bariatric Surgery Devices.
Figure 2 Bariatric Surgery Devices Market, by Procedure, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
The market segmentation of Bariatric Surgery Devices, based on end-user includes, hospitals, specialty centers, ambulatory surgical centers. The hospitals segment held the majority share in 2022 in the Bariatric Surgery Devices market data. This is related to the expanding usage of bariatric surgery devices in hospitals and the accessibility of affordable medical care in clinics. The increased number of hospital and ophthalmology clinic mergers and acquisitions is expected to enhance the need for new installations in the future years.
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Bariatric Surgery Devices market accounted for USD 1.007 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The industry participants are conducting studies to assess the effectiveness of their surgeries to treat obesity due to rising obesity rates and significant government financing. For instance, bariatric procedures previously covered by Medicare for people with BMIs of 40 or higher were changed to cover anyone with BMIs of 30 or higher. Many people who were fat and couldn't afford the high costs of surgery, doctors, and hospitals benefited from this development. New product development, partnerships, partnerships, expansions, mergers, and acquisitions are the main strategies used by the organisations in the market.
Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3 BARIATRIC SURGERY DEVICES MARKET SHARE BY REGION 2022 (%)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Bariatric Surgery Devices market accounts for the second-largest market share. Ireland leads the way in the frightening rise of obesity across Europe. The WHO study on the European Modelling Obesity Project detailed the different interventions and financial burdens on healthcare systems associated with obesity if it is not treated. As a result, the government is sponsoring numerous academic institutions to develop novel approaches. Moreover, UK market of Bariatric Surgery Devices held the largest market share, and the Germany market of Bariatric Surgery Devices was the fastest growing market in the region.
Asia Pacific Bariatric Surgery Devices Market is expected to grow at the fastest CAGR from 2022 to 2030. This can be attributed to many obese people and rising medical tourism due to surgery performed at reasonable prices. The Procedures, which cost USD 25,000 in the US, are available in Asia Pacific nations for USD 12,000. To examine the variables connected to obesity in this country, even industrial firms have expanded their research facilities there. Further, the China market of Bariatric Surgery Devices held the largest market share, and the India market of Bariatric Surgery Devices was the fastest-growing market in the region.
Bariatric Surgery Devices Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of Bariatric Surgery Devices grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Bariatric Surgery Devices industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the Bariatric Surgery Devices industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Bariatric Surgery Devices industry has provided medicine with some of the most significant benefits. The Bariatric Surgery Devices market major player such Medtronic, TransEnterix Surgical Inc., Johnson & Johnson Services Inc., Apollo Endosurgery Inc., ReShape Lifesciences Inc.
A clinical-stage medical device firm is GI Dynamics Inc. It is developing and marketing a medical device called EndoBarrier designed to treat people with type 2 diabetes and obesity. To explore end barrier-induced changes in bile acid, which regulates glucose and energy balance, GI Dynamics Inc. and GSK partnered.
A Johnson & Johnson subsidiary is Ethicon, Inc., which they acquired to broaden and diversify the Johnson & Johnson product portfolio; it was established as a distinct business under the Johnson & Johnson brand in 1949. Since 1887, Ethicon has been producing surgical sutures and tools for wound closure. Ethicon invested about $3.2 million. The money was spent researching how weight loss surgery affects Type 2 diabetes and obesity.
Key Companies in the market of Bariatric Surgery Devices includes
Bariatric Surgery Devices Industry Developments
August 2022 As part of the agreement, Teleflex agreed to pay USD 170 million in cash up front and USD 130 million more if certain commercial targets were achieved.
January 2022 Apollo Hospital in Hyderabad claimed it had carried out the first Full Robotic Bariatric surgery in Telugu. Hibibo Abdulle Mohamed, a 40-year-old Somalian who weighed 180 kg and had several health issues, underwent the procedure.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 2.2 billion |
| Market Size 2023 | USD 2.33 billion |
| Market Size 2032 | USD 3.5 billion |
| Compound Annual Growth Rate (CAGR) | 6.1 % (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018 - 2021 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Procedure, End-User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Medtronic, TransEnterix Surgical Inc., Johnson & Johnson Services Inc., Apollo Endosurgery Inc., ReShape Lifesciences Inc. |
| Key Market Opportunities | Growing acceptance for laparoscopic surgery |
| Key Market Dynamics | Growing obesity incidence rate in adults and cutting-edge robotic technologies |
Bariatric Surgery Devices Market Highlights:
Frequently Asked Questions (FAQ) :
The Bariatric Surgery Devices market size was valued at USD 2.2 Billion in 2022.
The market is projected to grow at a CAGR of 6.1% during the forecast period, 2023-2032.
North America had the largest share in the market
The key players in the market are Medtronic, TransEnterix Surgical Inc., Johnson & Johnson Services Inc., Apollo Endosurgery Inc., ReShape Lifesciences Inc.
The minimally invasive surgical devices category dominated the market in 2022.
The hospitals had the largest share in the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
